Heavy Bleeding in Perimenopause

What Heavy Perimenopausal Bleeding Looks Like

Clinically, "heavy menstrual bleeding" (HMB) is defined by impact rather than precise volume:

• Soaking through a pad or tampon every 1-2 hours for several consecutive hours
• Bleeding lasting more than 7 days
• Passing large clots (golf-ball-sized or larger)
• Needing to use double protection (pad and tampon together)
• Needing to change protection during the night
• Bleeding through clothes or bedding
• Restricting daily activities because of bleeding
• Symptoms of anemia — fatigue, shortness of breath, dizziness, pale skin

Clinicians sometimes use a Pictorial Blood Assessment Chart (PBAC) to estimate blood loss, but in day-to-day care, the impact on your life and anemia symptoms often matter more than a specific number.

In perimenopause specifically, heavy bleeding often comes with unpredictable timing — long gaps between cycles followed by very heavy bleeding when a cycle finally arrives.

Why Perimenopausal Bleeding Becomes Heavy

The dominant mechanism is anovulatory cycles:

• In a normal ovulatory cycle, the ovary releases an egg, then produces progesterone for ~14 days. Progesterone matures the endometrium and limits its growth
• In an anovulatory cycle (common in perimenopause), no egg is released, and progesterone production drops dramatically
• Estrogen continues unopposed, building a thick endometrial lining
• When the lining eventually sheds, bleeding can be heavy and prolonged

Other perimenopausal contributors:

• Increased prevalence of structural causes in midlife — uterine fibroids, polyps, adenomyosis are more common at 40+
• Endometrial hyperplasia — thickened lining from prolonged unopposed estrogen ¹; needs evaluation as it can be precancerous
• Bleeding disorders — usually known by midlife but can present
• Anticoagulant medications — common at midlife
• Thyroid dysfunction

PALM-COEIN — ACOG's Classification of Abnormal Uterine Bleeding ²

PALM-COEIN is the canonical clinical framework for organizing the differential of heavy or abnormal bleeding. PALM = structural causes (visible on imaging or histology); COEIN = non-structural causes.

Is This Normal? When to See a Doctor

Some increase in bleeding heaviness during perimenopause is common, but clinically significant heavy bleeding warrants evaluation — both to rule out structural causes and to relieve symptoms.

Specifically, see a clinician if:

• You're soaking through protection hourly
• Periods last >7 days
• You're passing large clots
• You're feeling fatigued, dizzy, or short of breath (possible anemia)
• You're missing work or activities because of bleeding
• The pattern represents a significant change from your previous norm

Clinical Red Flags — Urgent Evaluation Required

• Bleeding after 12 consecutive months without a period (postmenopausal bleeding) — always urgent; possible endometrial cancer
• Soaking through pads/tampons every hour for several hours — possible severe bleeding; emergency evaluation
• Lightheadedness, fainting, or syncope with bleeding
• Bleeding with severe pelvic pain
• Pregnancy possibility (perimenopausal women can still conceive)
• Bleeding plus weight loss, fevers, or significant systemic symptoms
• Family history of endometrial, ovarian, or colon cancer plus abnormal bleeding (possible Lynch syndrome considerations)
• Persistent bleeding despite hormonal treatment — needs structural workup

What You Can Do About It

The workup typically includes a history of your bleeding pattern, medications (including blood thinners or hormone therapy), pelvic exam, pregnancy test when relevant (since pregnancy is still possible until menopause is complete), CBC and often iron studies (ferritin), thyroid testing when indicated, and transvaginal ultrasound.

Endometrial biopsy is commonly recommended ¹, ⁴ for abnormal uterine bleeding at age 45 or older, and in younger patients when there are risk factors (such as obesity, PCOS, chronic anovulation, tamoxifen use, diabetes, or family history of endometrial/colon cancer), persistent bleeding, or failure of initial treatment.

If bleeding is severe enough to cause fainting, chest pain, shortness of breath, palpitations, or weakness, emergency treatment may be needed — including urgent labs, IV fluids, iron, blood transfusion, or short-term high-dose hormonal therapy under medical supervision.

Treat anemia first if present

Iron supplementation (oral, sometimes IV if severe) ³ restores energy and prevents complications while underlying treatment is initiated.

While standard labs flag iron deficiency only when ferritin drops well below normal, fatigue and hair loss can occur at higher levels — concierge practices often target ferritin repletion above the bare clinical minimum, individualized to symptoms and the underlying cause.

Address weight where it's a contributor

Excess adipose tissue converts androgens into estrone (a peripheral estrogen) — this can drive a thicker uterine lining and heavier bleeding even outside of standard ovarian cycles. For patients with elevated BMI and heavy bleeding, clinically supervised medical weight loss (including GLP-1 therapy when indicated) can reduce peripheral estrogen production and improve cycle regularity over time. This isn't a fast fix for an active heavy episode, but it's a meaningful upstream intervention.

Hormonal stabilization (most common first-line)

• Combined hormonal contraception ¹ (pill, patch, ring) — stabilizes cycles, reduces bleeding 30-50%, provides contraception. Not appropriate for everyone — typically avoided in women with migraine with aura, uncontrolled hypertension, prior blood clots, thrombophilia, certain liver disease, estrogen-sensitive cancers, or some smokers over age 35
• 52 mg levonorgestrel IUD (Mirena, Liletta) — first-line for heavy menstrual bleeding; major bleeding reduction over time; many women stop bleeding entirely after 6-12 months. Mirena is FDA-approved specifically for heavy menstrual bleeding. Lower-dose LNG IUDs (Kyleena, Skyla) are not indicated for HMB. Also provides long-acting contraception (5-8 years)
• Oral progestins (cyclic or continuous) — particularly useful when estrogen is contraindicated
• Depot medroxyprogesterone (DMPA, Depo-Provera) — injection, suppresses periods over time. Generally not preferred in perimenopausal women because of negative effects on bone mineral density and frequent weight gain — discuss alternatives if other options are appropriate

Non-hormonal options

• Tranexamic acid (Lysteda®) ³ — non-hormonal medication taken only during bleeding days; reduces blood loss substantially; FDA-approved for heavy menstrual bleeding. Not right for everyone — caution or avoidance in patients with prior blood clots, clotting disorders, renal impairment, or blood in the urine; clinician judgment required when used alongside combined hormonal contraception
• NSAIDs such as ibuprofen or naproxen — modestly reduce bleeding and help cramps when taken during periods. Not appropriate for everyone, especially people with stomach ulcers, kidney disease, certain heart conditions, or blood-thinner use

Procedural options

• Hysteroscopy with targeted treatment — for polyps or submucosal fibroids; outpatient
• Endometrial ablation — destroys the endometrial lining to reduce or eliminate bleeding; typically a one-time procedure. Endometrial ablation is for people who do not want future pregnancy. Pregnancy can still occur afterward and can be dangerous (risks include placenta accreta, uterine rupture, severe maternal hemorrhage), so patients need an individualized plan for reliable contraception after the procedure. Not appropriate if there are certain uterine cavity abnormalities, suspected cancer or precancer, or other factors that make the procedure less safe or less likely to work.
• Uterine artery embolization — for fibroid-driven bleeding; preserves uterus
• Myomectomy — surgical removal of fibroids while preserving uterus
• Hysterectomy — definitive; appropriate when other options have failed or with significant pathology

Lifestyle / supportive

• Iron-rich diet plus iron supplementation if anemic
• Track bleeding to inform treatment decisions
• Pad/tampon supply readiness during the heavy phase

Get Started with JumpstartMD

Heavy perimenopausal bleeding is treatable — and prolonged, untreated heavy bleeding has cumulative consequences (anemia, fatigue, missed work).

JumpstartMD's perimenopause and menopause care is part of our broader Total Health Optimization approach — a medically-supervised bioidentical hormone therapy program delivered by an expert team of licensed clinicians (under physician oversight), supported by lifestyle coaching for the behavioral side of care. Treatment balances five key hormones — estrogen, progesterone, DHEA, testosterone, and thyroid — through pills, creams, patches, injections, or subcutaneous pellet therapy (in-person visits only).

The program follows a structured pathway: a phone connection with our team, an online health questionnaire, comprehensive hormone labs at Quest Laboratories, a clinical consultation to review results, a personalized treatment plan, and regular follow-ups to fine-tune dosing as your body responds. Care is delivered in-person at our 14 California clinics or online from anywhere in California. When weight or metabolic health is contributing to your symptoms, BHRT is coordinated with our medical weight loss program in the same care plan.

Membership benefits include comprehensive lab testing, ongoing support and monitoring, exclusive member pricing on products, and concierge medical insurance claims assistance for PPO out-of-network plans (FSA/HSA accepted).

Ready to talk?

Book FREE Consultation

Share your details and a JumpstartMD team member will reach out shortly. Or call 408.478.3496 for your free, no-obligation consultation.